We are moving healthcare forward
Digital therapeutics (DTx) are a crucial component of the emerging healthcare systems of the future, addressing critical gaps in care, and offering unprecedented access to safe and effective treatments through the power of technology.
.svg)
Building a digital bridge into the clinical setting
The traditional model of a 15 minute doctor’s visit, followed by a prescription, is fading away. Sidekick's DTx products complement traditional medical treatments, provide a digital bridge into the clinical setting, and give patients access to personalized treatments via smartphones and tablets, empowering them to take control of their own health.
Our platform powers the industry's broadest DTx portfolio
The major challenge facing the world’s healthcare systems is how to support and treat people with multiple lifestyle-related diseases. The cornerstone of Sidekick’s approach is our multi-chronic digital care platform, allowing us to scale the production of DTx products across all major chronic diseases.
Augmenting pharmacotherapy
Sidekick operates its platform in partnership with some of the biggest names in the pharmaceutical industry to augment pharmacotherapy. We develop integrated combination therapeutics consisting of a drug (Rx) and a DTx to create standalone, prescription DTx products (PDTs).
Reducing the cost of care
Our DTx products are also deployed in partnership with leading health insurance majors and healthcare providers, focusing on the support of the 30% multi-chronic population that drives 70% of healthcare costs. Through our growing library of DTx products, we aim to help them manage their symptoms, provide regular remote patient monitoring, and prevent serious illnesses and hospital visits.
Because multi-chronic populations account for the majority of global healthcare costs, the benefit for health insurers and healthcare providers is clear.
Prevention, treatment and management of this population will sharply reduce overall costs, and drastically increase the quality-adjusted life years (QALYs) of the relevant populations.